Cancer genetics
Researchers at Kyushu University have identified zinc finger protein 282 (ZNF282) as a novel gene that contributes to the progression of colorectal cancer (CRC). According to a study published in Cancer Science, high expression of ZNF282 was associated with distant metastasis and poor prognosis in CRC patients. The study also
Cancer genetics
New research has shed light on the shortcomings of traditional chemotherapy and the potential of targeted drug delivery systems (DDS) for enhanced cancer treatment. According to a study published in the Journal of Drug Delivery Science and Technology, cancer remains a major global health concern, necessitating the development of novel
Cancer
A recent study published in the JMIR Cancer journal has found that publicly available information on genomic medicine at National Cancer Institute-designated cancer centers (NCI-CCs) in the United States is often lacking. Despite efforts to provide personalized care and incorporate genetic testing, many centers fail to publicly communicate their efforts
Cancer genetics
Research from Nanjing University has shed new light on the potential of nanomachines in cancer gene therapy, leveraging CRISPR-Cas9 technology to precisely edit genes responsible for tumorigenesis and immunity. A near-infrared upconversion theranostic nanomachine has been devised to mediate precise gene therapy, incorporating a logic DNAzyme system and manganese-modified nanoparticles
Cancer genetics
Researchers at the State Research Center, in collaboration with international colleagues, have made a significant contribution to the field of cancer gene therapy. According to a recent study published in Acta Naturae, they have engineered targeted nanoliposomes capable of delivering large quantities of boronophenylalanine into cancer cells. This innovation may
Cancer genetics
Researchers from the University of Texas Southwestern Medical Center have developed a novel method, Categorical and Phenotypic Image Synthetic Learning (CATphishing), to address the challenges of traditional federated learning in medical imaging. This innovative approach uses Latent Diffusion Models to generate synthetic multi-contrast three-dimensional magnetic resonance imaging data, eliminating the
Cancer genetics
New research has shed light on the shortcomings of traditional chemotherapy and the potential of targeted drug delivery systems (DDS) for enhanced cancer treatment. According to a study published in the Journal of Drug Delivery Science and Technology, cancer remains a major global health concern, necessitating the development of novel
Cancer
Researchers at the State Research Center, in collaboration with international colleagues, have made a significant contribution to the field of cancer gene therapy. According to a recent study published in Acta Naturae, they have engineered targeted nanoliposomes capable of delivering large quantities of boronophenylalanine into cancer cells. This innovation may
Cancer
Researchers at the State Research Center, in collaboration with international colleagues, have made a significant contribution to the field of cancer gene therapy. According to a recent study published in Acta Naturae, they have engineered targeted nanoliposomes capable of delivering large quantities of boronophenylalanine into cancer cells. This innovation may
Cancer genetics
Researchers from the University of Texas Southwestern Medical Center have developed a novel method, Categorical and Phenotypic Image Synthetic Learning (CATphishing), to address the challenges of traditional federated learning in medical imaging. This innovative approach uses Latent Diffusion Models to generate synthetic multi-contrast three-dimensional magnetic resonance imaging data, eliminating the
Cancer genetics
New research has shed light on the shortcomings of traditional chemotherapy and the potential of targeted drug delivery systems (DDS) for enhanced cancer treatment. According to a study published in the Journal of Drug Delivery Science and Technology, cancer remains a major global health concern, necessitating the development of novel
Cancer genetics
Researchers at Kyushu University have identified zinc finger protein 282 (ZNF282) as a novel gene that contributes to the progression of colorectal cancer (CRC). According to a study published in Cancer Science, high expression of ZNF282 was associated with distant metastasis and poor prognosis in CRC patients. The study also
